Theoretical aspects of P-glycoprotein mediated drug efflux on the distribution volume of anaesthetic-related drugs in the brain - PubMed (original) (raw)
Theoretical aspects of P-glycoprotein mediated drug efflux on the distribution volume of anaesthetic-related drugs in the brain
R N Upton. Anaesth Intensive Care. 2002 Apr.
Abstract
P-glycoprotein in the membranes of endothelial cells actively transports some drugs out of the brain. The theoretical effect of P-glycoprotein mediated drug efflux on the cerebral distribution volumes of drugs was examined, with particular emphasis on anaesthetic-related drugs (often characterized by moderate to high permeability across the blood brain barrier due to their lipophilicity and intermediate molecular weight). An analytical equation for the cerebral distribution volume in the presence of the efflux was derived, and validated by modelling the same system using differential equations. The efflux was shown to lower both the membrane and intracellular drug concentrations in parallel, and to reduce the time required for brain:blood equilibration. The net effect of the efflux was governed by the ratio of the P-glycoprotein drug clearance from the membrane (Pcl) and the permeability of the membrane (PS). It was therefore a balance between the rate that a drug could be pumped out of the membrane by the efflux system, and the rate that the drug leaked back in due to the permeability of the membrane for the drug. The effect of the efflux was therefore more pronounced for drugs with membrane-limited cerebral kinetics (e.g. morphine), but was nevertheless significant for drugs with more flow-limited kinetics (e.g fentanyl). The cerebral distribution volume was also influenced by the free fraction in blood and the free fraction in the intracellular space in the conventional manner. There are no theoretical limitations to the P-glycoprotein system influencing the cerebral distribution volume of moderately lipophilic anaesthetic-related drugs.
Similar articles
- P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
Fromm MF. Fromm MF. Int J Clin Pharmacol Ther. 2000 Feb;38(2):69-74. doi: 10.5414/cpp38069. Int J Clin Pharmacol Ther. 2000. PMID: 10706193 Review. - In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier.
Ohnishi T, Tamai I, Sakanaka K, Sakata A, Yamashima T, Yamashita J, Tsuji A. Ohnishi T, et al. Biochem Pharmacol. 1995 May 17;49(10):1541-4. doi: 10.1016/0006-2952(95)00082-b. Biochem Pharmacol. 1995. PMID: 7763297 - Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line.
El Hafny B, Cano N, Piciotti M, Regina A, Scherrmann JM, Roux F. El Hafny B, et al. Biochem Pharmacol. 1997 Jun 1;53(11):1735-42. doi: 10.1016/s0006-2952(97)00093-2. Biochem Pharmacol. 1997. PMID: 9264327 - High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier.
Taccola C, Cartot-Cotton S, Valente D, Barneoud P, Aubert C, Boutet V, Gallen F, Lochus M, Nicolic S, Dodacki A, Smirnova M, Cisternino S, Declèves X, Bourasset F. Taccola C, et al. Eur J Pharm Sci. 2018 May 30;117:68-79. doi: 10.1016/j.ejps.2018.02.005. Epub 2018 Feb 7. Eur J Pharm Sci. 2018. PMID: 29427702 - A review on the relation between the brain-serum concentration ratio of drugs and the influence of P-glycoprotein.
Ejsing TB, Morling N, Linnet K. Ejsing TB, et al. Drug Metabol Drug Interact. 2007;22(2-3):113-29. doi: 10.1515/dmdi.2007.22.2-3.113. Drug Metabol Drug Interact. 2007. PMID: 17708063 Review.
Cited by
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
Löscher W, Potschka H. Löscher W, et al. NeuroRx. 2005 Jan;2(1):86-98. doi: 10.1602/neurorx.2.1.86. NeuroRx. 2005. PMID: 15717060 Free PMC article. Review. - Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
Syvänen S, Xie R, Sahin S, Hammarlund-Udenaes M. Syvänen S, et al. Pharm Res. 2006 Apr;23(4):705-17. doi: 10.1007/s11095-006-9780-0. Epub 2006 Apr 7. Pharm Res. 2006. PMID: 16575498 - Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.
Sjöstedt N, Kortejärvi H, Kidron H, Vellonen KS, Urtti A, Yliperttula M. Sjöstedt N, et al. Pharm Res. 2014 Jan;31(1):1-19. doi: 10.1007/s11095-013-1124-2. Pharm Res. 2014. PMID: 23797466 Review. - Blood-brain barrier: mechanisms governing permeability and interaction with peripherally acting μ-opioid receptor antagonists.
Viscusi ER, Viscusi AR. Viscusi ER, et al. Reg Anesth Pain Med. 2020 Sep;45(9):688-695. doi: 10.1136/rapm-2020-101403. Epub 2020 Jul 28. Reg Anesth Pain Med. 2020. PMID: 32723840 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources